Mayer Brown partner Gabriela Kennedy spoke on the panel entitled "Lessons from Round One".
For more information, please click on the button below.
Adapting US Practice to Patenting Pharmaceuticals in China
No-Poach and Non-Solicitation Agreements: Naked Antitrust Violations or Legitimate Business Arrangements
Using IP as Collateral: Locking ‘Trap Doors’ and Other Advanced IP Issues